Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

February 9, 2027

Study Completion Date

December 31, 2027

Conditions
Renal AnemiaPeritoneal Dialysis (PD)
Interventions
DRUG

Iron isomaltoside

Intravenous infusion of 1000mg iron isomaltoside as a single dose for over 15min. Iron isomaltoside 1000mg was diluted in 100ml of 0.9% saline.

DRUG

Ferrous succinate

Patients received ferrous succinate treatment orally given as 200mg twice a day for 8 weeks.

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Songjiang Hospital, Shanghai Jiao Tong University School of Medicine

UNKNOWN

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Chinese People's Liberation Army No 455 Hospital

OTHER_GOV

lead

Xie Jingyuan, MD

OTHER